{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:39:22Z","timestamp":1792744762650,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chongqing Medical Scientific Research Tackling Project","award":["2025GGXM003"],"award-info":[{"award-number":["2025GGXM003"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274518"],"award-info":[{"award-number":["82274518"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1007\/s00203-026-05231-8","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:16:15Z","timestamp":1792739775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Zhuhuang Granules alleviate psoriatic inflammation via restoring gut microbiota balance and enhancing intestinal barrier integrity"],"prefix":"10.1007","volume":"209","author":[{"given":"Yueyuan","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erle","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijunzi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"issue":"2S","key":"5231_CR1","first-page":"20","volume":"37","author":"AH Abbas","year":"2025","unstructured":"Abbas AH et al (2025a) Mitigative effects of a topically-applied combination of cimifugin and vinpocetine on a murine psoriasis-like model. Pharmakeftiki 37(2S):20\u201324","journal-title":"Pharmakeftiki"},{"issue":"12","key":"5231_CR2","doi-asserted-by":"publisher","first-page":"17089","DOI":"10.1007\/s00210-025-04317-2","volume":"398","author":"AH Abbas","year":"2025","unstructured":"Abbas AH et al (2025b) Suppressive effect of topical moxifloxacin on imiquimod-induced model of psoriasis in mice. Naunyn Schmiedebergs Arch Pharmacol 398(12):17089\u201317108","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"5231_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s10735-025-10654-6","volume":"56","author":"RJH AlBairmani","year":"2025","unstructured":"AlBairmani RJH et al (2025) D-limonene attenuates d-galactose-induced skin aging mouse model. J Mol Histol 56(6):364","journal-title":"J Mol Histol"},{"issue":"4","key":"5231_CR4","first-page":"1783","volume":"29","author":"BF Ali","year":"2025","unstructured":"Ali BF, Abu-raghif AR, Ridha-salman H (2025a) Protective effect of cinnarizine on imiquimod-induced mouse model of psoriasis. J Res Pharm 29(4):1783\u20131791","journal-title":"J Res Pharm"},{"issue":"3","key":"5231_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10735-025-10416-4","volume":"56","author":"BF Ali","year":"2025","unstructured":"Ali BF et al (2025b) Vildagliptin topical ointment: an effective treatment for imiquimod-induced psoriasis in mice. J Mol Histol 56(3):143","journal-title":"J Mol Histol"},{"issue":"19","key":"5231_CR6","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323(19):1945\u20131960","journal-title":"JAMA"},{"issue":"1","key":"5231_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-025-00630-5","volume":"11","author":"AW Armstrong","year":"2025","unstructured":"Armstrong AW et al (2025) Psoriasis. Nat Rev Dis Primers 11(1):45","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"5231_CR8","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3390\/nu12041082","volume":"12","author":"RM Chakaroun","year":"2020","unstructured":"Chakaroun RM, Massier L, Kovacs P (2020) Gut microbiome, intestinal permeability, and tissue bacteria in metabolic disease: perpetrators or bystanders? Nutrients 12(4):1082","journal-title":"Nutrients"},{"issue":"21","key":"5231_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262110428","volume":"26","author":"A Chervet","year":"2025","unstructured":"Chervet A et al (2025) Microbial biotransformation of chicory by Bacteroides fragilis: in vitro implications for obesity-related psoriasis. Int J Mol Sci 26(21):10428","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5231_CR10","doi-asserted-by":"publisher","first-page":"12754","DOI":"10.1038\/s41598-020-69537-3","volume":"10","author":"I Dei-Cas","year":"2020","unstructured":"Dei-Cas I et al (2020) Metagenomic analysis of gut microbiota in non-treated plaque psoriasis patients stratified by disease severity: development of a new Psoriasis-Microbiome Index. Sci Rep 10(1):12754","journal-title":"Sci Rep"},{"issue":"2","key":"5231_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","volume":"19","author":"F Di Vincenzo","year":"2024","unstructured":"Di Vincenzo F et al (2024) Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med 19(2):275\u2013293","journal-title":"Intern Emerg Med"},{"issue":"17","key":"5231_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179294","volume":"22","author":"K Dopytalska","year":"2021","unstructured":"Dopytalska K et al (2021) The role of epigenetic factors in psoriasis. Int J Mol Sci 22(17):9294","journal-title":"Int J Mol Sci"},{"key":"5231_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/srep20134","volume":"6","author":"L Grine","year":"2016","unstructured":"Grine L et al (2016) Topical imiquimod yields systemic effects due to unintended oral uptake. Sci Rep 6:20134","journal-title":"Sci Rep"},{"key":"5231_CR14","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3497767\/v1","author":"C Guo","year":"2023","unstructured":"Guo C et al (2023) The gut microbiota and psoriasis: a two-sample Mendelian randomization study Running title: Gut microbiota and psoriasis. Res Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-3497767\/v1","journal-title":"Res Sq"},{"key":"5231_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2024.100848","volume":"41","author":"S Hasegawa-Ishii","year":"2024","unstructured":"Hasegawa-Ishii S et al (2024) Chronic nasal inflammation early in life induces transient and long-term dysbiosis of gut microbiota in mice. Brain Behav Immun Health 41:100848","journal-title":"Brain Behav Immun Health"},{"issue":"5","key":"5231_CR16","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00580-025-03709-3","volume":"34","author":"MN Hussein","year":"2025","unstructured":"Hussein MN et al (2025) Flavonoids from Conyza canadensis mitigates CDNB-induced mouse model of atopic dermatitis. Comp Clin Pathol 34(5):987\u20131010","journal-title":"Comp Clin Pathol"},{"issue":"1","key":"5231_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2473524","volume":"17","author":"M Jimenez-Sanchez","year":"2025","unstructured":"Jimenez-Sanchez M et al (2025) The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential. Gut Microbes 17(1):2473524","journal-title":"Gut Microbes"},{"key":"5231_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1286344","volume":"14","author":"M Kamata","year":"2023","unstructured":"Kamata M, Tada Y (2023) Crosstalk: keratinocytes and immune cells in psoriasis. Front Immunol 14:1286344","journal-title":"Front Immunol"},{"issue":"15","key":"5231_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155405","volume":"21","author":"N Kanda","year":"2020","unstructured":"Kanda N, Hoashi T, Saeki H (2020) Nutrition and psoriasis. Int J Mol Sci 21(15):5405","journal-title":"Int J Mol Sci"},{"issue":"8","key":"5231_CR20","doi-asserted-by":"publisher","first-page":"6231","DOI":"10.1007\/s00210-024-03017-7","volume":"397","author":"AWM Khafaji","year":"2024","unstructured":"Khafaji AWM et al (2024) Ameliorative effects of topical ramelteon on imiquimod-induced psoriasiform inflammation in mice. Naunyn Schmiedebergs Arch Pharmacol 397(8):6231\u20136248","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"7","key":"5231_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072582","volume":"21","author":"M Komine","year":"2020","unstructured":"Komine M (2020) Recent advances in psoriasis research; the clue to mysterious relation to gut microbiome. Int J Mol Sci 21(7):2582","journal-title":"Int J Mol Sci"},{"key":"5231_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.lfs.2019.01.019","volume":"219","author":"X Li","year":"2019","unstructured":"Li X et al (2019) Hesperidin inhibits keratinocyte proliferation and imiquimod-induced psoriasis-like dermatitis via the IRS-1\/ERK1\/2 pathway. Life Sci 219:311\u2013321","journal-title":"Life Sci"},{"key":"5231_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115275","volume":"294","author":"T Li","year":"2022","unstructured":"Li T et al (2022) Potential effects and mechanisms of Chinese herbal medicine in the treatment of psoriasis. J Ethnopharmacol 294:115275","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"5231_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59603-5","volume":"14","author":"Y Li","year":"2024","unstructured":"Li Y et al (2024a) Assessing causal relationships between gut microbiota and psoriasis: evidence from two sample Mendelian randomization analysis. Sci Rep 14(1):8831","journal-title":"Sci Rep"},{"key":"5231_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1360972","volume":"15","author":"H Li","year":"2024","unstructured":"Li H et al (2024b) Sijunzi decoction alleviates inflammation and intestinal epithelial barrier damage and modulates the gut microbiota in ulcerative colitis mice. Front Pharmacol 15:1360972","journal-title":"Front Pharmacol"},{"issue":"6","key":"5231_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/nu13062010","volume":"13","author":"W Lu","year":"2021","unstructured":"Lu W et al (2021) Potential role of probiotics in ameliorating psoriasis by modulating gut microbiota in imiquimod-induced psoriasis-like mice. Nutrients 13(6):2010","journal-title":"Nutrients"},{"issue":"3","key":"5231_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167634","volume":"1871","author":"P Lundquist","year":"2025","unstructured":"Lundquist P et al (2025) Mild-to-moderate psoriasis is associated with subclinical inflammation in the duodenum and a tendency of disturbed intestinal barrier. Biochim Biophys Acta Mol Basis Dis 1871(3):167634","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"5231_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e41672","volume":"11","author":"M Memariani","year":"2025","unstructured":"Memariani M, Memariani H (2025) New horizons in the treatment of psoriasis: modulation of gut microbiome. Heliyon 11(1):e41672","journal-title":"Heliyon"},{"issue":"9","key":"5231_CR29","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3390\/cells11091513","volume":"11","author":"S Morin","year":"2022","unstructured":"Morin S et al (2022) Alpha-linolenic acid modulates T cell incorporation in a 3D tissue-engineered psoriatic skin model. Cells 11(9):1513","journal-title":"Cells"},{"issue":"14","key":"5231_CR30","first-page":"467","volume":"121","author":"U Mrowietz","year":"2024","unstructured":"Mrowietz U et al (2024) Psoriasis as a systemic disease. Dtsch Arztebl Int 121(14):467\u2013472","journal-title":"Dtsch Arztebl Int"},{"issue":"8","key":"5231_CR31","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.3390\/ijms22083998","volume":"22","author":"I Olejniczak-Staruch","year":"2021","unstructured":"Olejniczak-Staruch I et al (2021) Alterations of the skin and gut microbiome in psoriasis and psoriatic arthritis. Int J Mol Sci 22(8):3998","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5231_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111191","volume":"40","author":"GV Pinget","year":"2022","unstructured":"Pinget GV et al (2022) Dysbiosis in imiquimod-induced psoriasis alters gut immunity and exacerbates colitis development. Cell Rep 40(7):111191","journal-title":"Cell Rep"},{"issue":"3","key":"5231_CR33","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1007\/s00210-024-03406-y","volume":"398","author":"H Ridha-Salman","year":"2025","unstructured":"Ridha-Salman H et al (2025) The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation. Naunyn Schmiedebergs Arch Pharmacol 398(3):2695\u20132715","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"5231_CR34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13062-025-00675-2","volume":"20","author":"F Shi","year":"2025","unstructured":"Shi F et al (2025) Spleen granulopoiesis in psoriasis immune microenvironment aggravates psoriasis via IL-6\/P-STAT3 signaling. Biol Direct 20(1):96","journal-title":"Biol Direct"},{"issue":"1","key":"5231_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-90480-4","volume":"11","author":"H Shinno-Hashimoto","year":"2021","unstructured":"Shinno-Hashimoto H et al (2021) Abnormal composition of microbiota in the gut and skin of imiquimod-treated mice. Sci Rep 11(1):11265","journal-title":"Sci Rep"},{"issue":"2","key":"5231_CR36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","volume":"66","author":"I Sieminska","year":"2024","unstructured":"Sieminska I, Pieniawska M, Grzywa TM (2024) The immunology of psoriasis-current concepts in pathogenesis. Clin Rev Allergy Immunol 66(2):164\u2013191","journal-title":"Clin Rev Allergy Immunol"},{"key":"5231_CR37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/JIR.S292544","volume":"14","author":"M Sikora","year":"2021","unstructured":"Sikora M et al (2021) Clinical implications of intestinal barrier damage in psoriasis. J Inflamm Res 14:237\u2013243","journal-title":"J Inflamm Res"},{"issue":"2","key":"5231_CR38","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jid.2025.09.005","volume":"146","author":"CC Smith","year":"2026","unstructured":"Smith CC et al (2026) Reevaluating the imiquimod model: a barrier to translational progress in psoriasis. J Invest Dermatol 146(2):322\u2013327. https:\/\/doi.org\/10.1016\/j.jid.2025.09.005","journal-title":"J Invest Dermatol"},{"issue":"5","key":"5231_CR39","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1590\/1678-4162-12583","volume":"74","author":"T Su","year":"2022","unstructured":"Su T et al (2022) Characteristic of decreased bacterial diversity in psoriasis. Arq Bras Med Vet Zootec 74(5):767\u2013777","journal-title":"Arq Bras Med Vet Zootec"},{"issue":"6","key":"5231_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/exd.70128","volume":"34","author":"J Tang","year":"2025","unstructured":"Tang J et al (2025) Psychological stress overactivates IL-23\/Th17 inflammatory axis and increases cDC2 in imiquimod-induced psoriasis models of C57BL\/6 mice. Exp Dermatol 34(6):e70128","journal-title":"Exp Dermatol"},{"key":"5231_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105538","volume":"119","author":"L Wang","year":"2022","unstructured":"Wang L et al (2022a) Baicalin ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice through modulating skin barrier function, gut microbiota and JAK\/STAT pathway. Bioorg Chem 119:105538","journal-title":"Bioorg Chem"},{"key":"5231_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812996","volume":"13","author":"N Wang","year":"2022","unstructured":"Wang N et al (2022b) Altered fecal metabolomics and potential biomarkers of psoriatic arthritis differing from rheumatoid arthritis. Front Immunol 13:812996","journal-title":"Front Immunol"},{"issue":"18","key":"5231_CR43","doi-asserted-by":"publisher","first-page":"9233","DOI":"10.3390\/ijms26189233","volume":"26","author":"L Wang","year":"2025","unstructured":"Wang L et al (2025a) Advances in psoriasis research: decoding immune circuits and developing novel therapies. Int J Mol Sci 26(18):9233","journal-title":"Int J Mol Sci"},{"key":"5231_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156201","volume":"275","author":"J Wang","year":"2025","unstructured":"Wang J et al (2025b) Integrating network pharmacology and pharmacological evaluation for investigating the active ingredient of Chinese herbal formula Zhuhuang granule in psoriasis. Pathol Res Pract 275:156201","journal-title":"Pathol Res Pract"},{"issue":"24","key":"5231_CR45","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1097\/CM9.0000000000001197","volume":"133","author":"CY Xiao","year":"2020","unstructured":"Xiao CY et al (2020) Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis. Chin Med J 133(24):2910\u20132918","journal-title":"Chin Med J"},{"issue":"3","key":"5231_CR46","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1142\/S0192415X20500275","volume":"48","author":"YY Xu","year":"2020","unstructured":"Xu YY et al (2020) The role of Th17\/Treg axis in the traditional Chinese medicine intervention on immune-mediated inflammatory diseases: a systematic review. Am J Chin Med 48(3):535\u2013558","journal-title":"Am J Chin Med"},{"key":"5231_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1174331","volume":"10","author":"Y Xue","year":"2023","unstructured":"Xue Y et al (2023) Gut microbiota and atopic dermatitis: a two-sample Mendelian randomization study. Front Med 10:1174331","journal-title":"Front Med"},{"issue":"4","key":"5231_CR48","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/s41423-021-00661-4","volume":"18","author":"W Yang","year":"2021","unstructured":"Yang W, Cong Y (2021) Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases. Cell Mol Immunol 18(4):866\u2013877","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"5231_CR49","first-page":"269","volume":"21","author":"Z Yang","year":"2001","unstructured":"Yang Z, Ouyang H, Luo WH (2001) Clinical study on effect of zhuhuang granule no. 2 in treating psoriasis with liver-qi stagnancy. Zhongguo Zhong Xi Yi Jie He Za Zhi 21(4):269\u2013271","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"5231_CR50","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jep.2016.08.028","volume":"194","author":"Z Yang","year":"2016","unstructured":"Yang Z et al (2016) MicroRNA-146a and miR-99a are potential biomarkers for disease activity and clinical efficacy assessment in psoriasis patients treated with traditional Chinese medicine. J Ethnopharmacol 194:727\u2013732","journal-title":"J Ethnopharmacol"},{"issue":"11","key":"5231_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29112410","volume":"29","author":"X Yang","year":"2024","unstructured":"Yang X et al (2024) Metabolic profiling for unveiling mechanisms of kushenol F against imiquimod-induced psoriasis with UHPLC\/MS analysis. Molecules 29(11):2410","journal-title":"Molecules"},{"issue":"8","key":"5231_CR52","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00403-024-03288-3","volume":"316","author":"H Yanping","year":"2024","unstructured":"Yanping H et al (2024) Yinxie I formula attenuates imiquimod-induced psoriasis-like skin inflammation via IL-23\/IL-17 axis. Arch Dermatol Res 316(8):540","journal-title":"Arch Dermatol Res"},{"issue":"7","key":"5231_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159539","volume":"11","author":"Z Z\u00e1kostelsk\u00e1","year":"2016","unstructured":"Z\u00e1kostelsk\u00e1 Z et al (2016) Intestinal microbiota promotes psoriasis-like skin inflammation by enhancing Th17 response. PLoS ONE 11(7):e0159539","journal-title":"PLoS ONE"},{"issue":"1","key":"5231_CR54","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12866-021-02125-1","volume":"21","author":"X Zhang","year":"2021","unstructured":"Zhang X et al (2021) Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients. BMC Microbiol 21(1):78","journal-title":"BMC Microbiol"},{"key":"5231_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1487402","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang H et al (2024) Effects of Huang-Lian-Jie-Du decoction on improving skin barrier function and modulating T helper cell differentiation in 1-chloro-2,4-dinitrobenzene-induced atopic dermatitis mice. Front Pharmacol 15:1487402","journal-title":"Front Pharmacol"},{"issue":"1","key":"5231_CR56","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12876-024-03150-w","volume":"24","author":"L Zhangni","year":"2024","unstructured":"Zhangni L et al (2024) Clinical features and fecal microbiota characteristics of patients with both ulcerative colitis and axial spondyloarthritis. BMC Gastroenterol 24(1):56","journal-title":"BMC Gastroenterol"},{"key":"5231_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117714","volume":"324","author":"N Zhao","year":"2024","unstructured":"Zhao N et al (2024) Jianpi-Yangxue-Jiedu decoction improves the energy metabolism of psoriasis mice by regulating the electron transfer of oxidative phosphorylation. J Ethnopharmacol 324:117714","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"5231_CR58","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou X et al (2022) Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis 13(1):81","journal-title":"Cell Death Dis"},{"key":"5231_CR59","doi-asserted-by":"publisher","first-page":"1389925","DOI":"10.3389\/fcimb.2024.1389925","volume":"14","author":"Y Zhou","year":"2024","unstructured":"Zhou Y et al (2024) Repairing gut barrier by traditional Chinese medicine: roles of gut microbiota. Front Cell Infect Microbiol 14:1389925","journal-title":"Front Cell Infect Microbiol"},{"key":"5231_CR60","doi-asserted-by":"publisher","first-page":"1430586","DOI":"10.3389\/fcimb.2024.1430586","volume":"14","author":"X Zou","year":"2024","unstructured":"Zou X et al (2024) Gut microbiota and psoriasis: pathogenesis, targeted therapy, and future directions. Front Cell Infect Microbiol 14:1430586","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05231-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-05231-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05231-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:02:21Z","timestamp":1792742541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-05231-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["5231"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-05231-8","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The guidelines for the care and use of animals were approved by the Institutional Animal Care and Use Committee of the Hunan University of Chinese Medicine. All animal experiments were conducted in accordance with the approved institutional guidelines and reported in accordance with the ARRIVE 2.0 guidelines.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29"}}